Nine lawsuits have been filed in the U.S. District Court of Newark in New Jersey alleging the drug Digetek was dangerous and defective. One of the lawsuits includes the death of one patient after taking the drug. The lawsuits have been filed against Actavis Totowa LLL and its Iceland-based parent, Actavis Group, a generic pharmaceutical company. Similar lawsuits have been filed in West Virginia and California. The Distributors Mylan Pharmaceuticals Inc. and UDL Laboratories Inc. have also been named defendents. A nationwide recall of Digitek was instituted on April 25 when it was discovered that the pills were double the thickness thus double the dosage. A double dosage of Digitek poses a risk of digitalis toxicity resulting in symptoms of nausea and dizziness, low blood pressure and cardiac instability. The company informed the public that death can result as well and that they had received several reports of injuries.